metformin has been researched along with Hyperlipoproteinemia Type IV in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Hyperlipoproteinemia Type IV: A hypertriglyceridemia disorder, often with autosomal dominant inheritance. It is characterized by the persistent elevations of plasma TRIGLYCERIDES, endogenously synthesized and contained predominantly in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). In contrast, the plasma CHOLESTEROL and PHOSPHOLIPIDS usually remain within normal limits.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miklankova, D | 1 |
| Markova, I | 1 |
| Hüttl, M | 1 |
| Zapletalova, I | 1 |
| Poruba, M | 1 |
| Malinska, H | 1 |
| Franceschini, G | 1 |
| Sirtori, CR | 1 |
| Capurso, A | 1 |
| Weisgraber, KH | 1 |
| Mahley, RW | 1 |
2 other studies available for metformin and Hyperlipoproteinemia Type IV
| Article | Year |
|---|---|
Metformin Affects Cardiac Arachidonic Acid Metabolism and Cardiac Lipid Metabolite Storage in a Prediabetic Rat Model.
Topics: Animals; Arachidonic Acid; Basal Metabolism; Biomarkers; Cardiotonic Agents; Disease Models, Animal; | 2021 |
A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family.
Topics: Adolescent; Adult; Child; Cholesterol; Dietary Fats; Electrophoresis, Polyacrylamide Gel; Female; Hu | 1980 |